Table 4.

Results of second kidney biopsy for LN cases.

Results0 APOL1 RRA, n = 431 APOL1 RRA, n = 72 APOL1 RRA, n = 0p 0 vs ≥ 1 RRA
Proliferative lesion, %81.471.40.00.62
Classes (overall test)0.28*
  Class II1 (2.3)0 (0.0)0.01.00
  Class III (± V)15 (34.9)0 (0.0)0.00.09
  Class IV (± V)20 (46.5)5 (71.4)0.00.42
  Class V7 (16.3)2 (28.6)0.00.60
Median no. glomeruli (25–75th)12 (8–16)18 (10–22)0.00.11
Median global glomerular sclerosis (25–75th), %8.3 (0.0–28.2)4.0 (0.0–13.3)0.00.55
Crescents10 (23.8)4 (57.1)0.00.09
Median % crescents (25–75th), %0 (0–22)18.2 (5–75)0.00.03
Synechia to BC24 (70.6)2 (40.0)0.00.31
Fibrinoid necrosis2 (4.8)0 (0.0)0.01.00
Hyaline thrombi6 (4.7)1 (14.3)0.01.00
TMA2 (4.7)0 (0.0)0.01.00
Membranous component26 (61.9)5 (71.4)0.01.00
TIN4 (9.5)3 (42.9)0.00.05
Tubular atrophy ≥ 25%13 (37.1)2 (33.3)0.01.00
Interstitial fibrosis ≥ 25%16 (45.7)4 (66.7)0.00.41
Mean ± SD activity index3.9 ± 2.85.7 ± 3.50.00.32
Mean ± SD chronicity index4.4 ± 1.94.7 ± 0.60.00.80
  • * Chi-square test. Data are n (%) unless otherwise indicated. Data in bold face are statistically significant. LN: lupus nephritis; RRA: renal risk allele; BC: Bowman capsule; TMA: thrombotic microangiopathy; TIN: tubulointerstitial nephritis.